Literature DB >> 31262875

Quantitative Structure-Cytotoxicity Relationship of Azulene Amide Derivatives.

Kana Imanari1, Masashi Hashimoto1, Hidetsugu Wakabayashi2, Noriyuki Okudaira3, Kenjiro Bandow4, Junko Nagai5, Mineko Tomomura4, Akito Tomomura4, Yoshihiro Uesawa5, Hiroshi Sakagami6.   

Abstract

BACKGROUND/AIM: Very few studies of anticancer activity of azulene amides led us to investigate the cytotoxicity of 21 N-alkylazulene-1-carboxamides introduced either with 3-methyl [1-7], 7-isopropyl-3-methyl [8-14] or 2-methoxy group [15-21] Materials and
Methods: Tumor-specificity (TS) was calculated by the ratio of mean 50% cytotoxic concentration (CC50) against three normal human oral mesenchymal cells to that against four human oral squamous cell carcinoma (OSCC) cell lines. Potency-selectivity expression (PSE) was calculated by dividing TS value by CC50 value against OSCC cell lines. Apoptosis-inducing activity was evaluated by caspase-3 activation and appearance of subG1 cell population.
RESULTS: [8-14] showed higher TS and PSE values, than [1-7] and [15-21] The most active compound [8-14] induced apoptosis in C9-22 OSCC cells at 4-times higher CC50 Quantitative structure-activity relationship analysis of [1-14] demonstrated that their tumor-specificity was correlated with chemical descriptors that explain the molecular shape and hydrophobicity.
CONCLUSION: 7-Isopropyl-3-methyl-N-propylazulene-1-carboxamide [8] can be a potential candidate of lead compound for manufacturing new anticancer drug. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Azulene amides; QSAR; apoptosis tumor specificity; chemical descriptor; hydrophobicity; molecular shape; oral squamous cell carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31262875     DOI: 10.21873/anticanres.13497

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Development of Heterocycle-Substituted and Fused Azulenes in the Last Decade (2010-2020).

Authors:  Taku Shoji; Tetsuo Okujima; Shunji Ito
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

2.  Tumor-Specificity, Neurotoxicity, and Possible Involvement of the Nuclear Receptor Response Pathway of 4,6,8-Trimethyl Azulene Amide Derivatives.

Authors:  Kotone Naitoh; Yuta Orihara; Hiroshi Sakagami; Takumi Miura; Keitaro Satoh; Shigeru Amano; Kenjiro Bandow; Yosuke Iijima; Kota Kurosaki; Yoshihiro Uesawa; Masashi Hashimoto; Hidetsugu Wakabayashi
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.